EVH - Evolent Health, Inc. News

Truist Securities Downgrades Evolent Health to Hold, Maintains Price Target to $7

Truist Securities analyst Jailendra Singh downgrades Evolent Health (NYSE:EVH) from Buy to Hold a

Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?

Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. T

Truist Securities Maintains Buy on Evolent Health, Raises Price Target to $7

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and rais

Rumble, Agilon Health And Oscar Health Among Stocks Moving Higher On Thursday

Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb

247wallst.com

Agentic AI Powers U.S. Healthcare Stocks

Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating

Citigroup Maintains Buy on Evolent Health, Raises Price Target to $5.5

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the

marketbeat.com

Evolent Health Q1 Earnings Call Highlights

Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with

seekingalpha.com

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Needham Maintains Buy on Evolent Health, Raises Price Target to $5

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business per

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Es

Evolent Health Affirms FY2026 Sales Guidance of $2.400B-$2.600B vs $2.487B Est.

Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400

Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate.

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst cons

Evolent Announces First Quarter 2026 Results

WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on ach

Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Evolent Health, Inc (NYSE: EVH - Get Free Report) has earned an average rating of "Moderate Buy" fro

Evolent announces appointment of Archie Mayani as chief product officer

Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group a

8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH

8 Knots Management LLC trimmed its holdings in shares of Evolent Health, Inc (NYSE: EVH) by 39.3% in

Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $6

Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and

Evolent to Participate in Upcoming Investor Conferences

WASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on ach

Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $4

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the

UBS Maintains Buy on Evolent Health, Lowers Price Target to $5

UBS analyst Kevin Caliendo maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price ta

seekingalpha.com

Evolent Health: Cheap, Levered, But Ready To Rebound

Evolent Health, Inc. is rated a Buy, with turnaround momentum and risk/reward now favoring upside af

Truist Securities Maintains Buy on Evolent Health, Lowers Price Target to $6

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and lowe

seekingalpha.com

Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript

Needham Maintains Buy on Evolent Health, Lowers Price Target to $4

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price

RBC Capital Maintains Sector Perform on Evolent Health, Lowers Price Target to $3

RBC Capital analyst Ryan Halsted maintains Evolent Health (NYSE:EVH) with a Sector Perform and lo

Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

This First Solar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

BTIG Maintains Buy on Evolent Health, Lowers Price Target to $8

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price tar

Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business per

Evolent Health (EVH) Q4 Earnings Top Estimates

Evolent Health (EVH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensu

Evolent Health Q4 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $468.719M Beat $468.701M Estimate

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.08 per share which beat the analyst cons

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Compan

Earnings Scheduled For February 24, 2026

Evolent Health (NYSE:EVH) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?

Shares of Evolent Health, Inc (NYSE: EVH - Get Free Report) crossed below its 50-day moving average

Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026

WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achi

Deep Dive Into Evolent Health Stock: Analyst Perspectives (11 Ratings)

BTIG Maintains Buy on Evolent Health, Lowers Price Target to $10

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price tar

Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $6

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the

The Analyst Verdict: Evolent Health In The Eyes Of 9 Experts

Citizens Maintains Market Outperform on Evolent Health, Lowers Price Target to $10

Citizens analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform

Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Evolent Health, Inc (NYSE: EVH - Get Free Report) have earned an average recommendation of

Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $9.5

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the

JP Morgan Maintains Overweight on Evolent Health, Lowers Price Target to $7

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and lowers th

Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $9

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers

BMO Capital Initiates Coverage On Evolent Health with Outperform Rating, Announces Price Target of $

BMO Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform

Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $12

Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and